ADJUTEC PHARMA AS
Organization
- CEO
- JL
- Chairman of the board
- ØK
- Years since formation
- 6 years
- since Nov 21, 2019
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 49,088
- 1 share class
- Total number of shareholders
- 28
- 25 companies, 3 persons
Financials
- Annual total result 2024
- -1,455,022
- NOK
- Total equity 2024
- 33,344,515
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
JL | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
KE | Board Member | - |
PR 1953 | Board Member | 46.27 % indirectly |
| Board Member | 6.32 % indirectly | |
| Board Member | - | |
ØK | Chairman | - |
EF | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
PR 1953 | Board Member | 46.27 % indirectly |
CS 1956 | - | 9.41 % indirectly |
| Board Member | 6.32 % indirectly | |
EH | - | 5.6 % indirectly |
BK 1959 | - | 3.41 % indirectly |
| - | 3.24 % indirectly | |
CG | - | 3.14 % indirectly |
MT 1954 | - | 2.09 % indirectly |
KM | - | 2.03 % indirectly |
TA 1967 | - | 1.03 % indirectly |
Last update: Jan 28, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 22,715 | 46.27 % | |
| Ordinary shares | 4,620 | 9.41 % | |
| Ordinary shares | 2,648 | 5.39 % | |
| Ordinary shares | 2,386 | 4.86 % | |
| Ordinary shares | 2,080 | 4.24 % | |
| Ordinary shares | 1,675 | 3.41 % | |
| Ordinary shares | 1,588 | 3.24 % | |
| Ordinary shares | 1,511 | 3.08 % | |
| Ordinary shares | 1,176 | 2.4 % | |
| Ordinary shares | 1,020 | 2.08 % | |
| Ordinary shares | 883 | 1.8 % | |
| Ordinary shares | 837 | 1.71 % | |
| Ordinary shares | 726 | 1.48 % | |
| Ordinary shares | 718 | 1.46 % | |
| Ordinary shares | 706 | 1.44 % | |
| Ordinary shares | 664 | 1.35 % | |
| Ordinary shares | 664 | 1.35 % | |
| Ordinary shares | 546 | 1.11 % | |
| Ordinary shares | 506 | 1.03 % | |
| Ordinary shares | 353 | 0.72 % | |
| Ordinary shares | 300 | 0.61 % | |
| Ordinary shares | 215 | 0.44 % | |
| Ordinary shares | 152 | 0.31 % | |
| Ordinary shares | 136 | 0.28 % | |
SA | Ordinary shares | 124 | 0.25 % |
| Ordinary shares | 90 | 0.18 % | |
| Ordinary shares | 39 | 0.08 % | |
RR | Ordinary shares | 10 | 0.02 % |
Shares owned by the ADJUTEC PHARMA AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 706 | 1.44 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 7,333,247 | 7,841,775 | 6,277,612 |
Annual Total Result | -1,455,022 | -9,533,948 | -17,150,598 | -3,515,968 |
Total assets | 43,418,401 | 18,091,362 | 33,992,317 | 32,986,867 |
Total liabilities | 10,073,886 | 23,877 | 6,390,884 | 226,916 |
Total equity | 33,344,515 | 18,067,485 | 27,601,433 | 32,759,951 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 7,333,247 | 7,841,775 | 6,277,612 |
Total operating costs | 2,100,420 | 20,379,920 | 31,237,050 | 11,493,174 |
Operating result | -2,100,420 | -13,046,673 | -23,395,275 | -5,215,562 |
Financial income/costs | 219,576 | -168,529 | 172,799 | -182,943 |
Profit before tax | -1,880,844 | -13,215,202 | -23,222,476 | -5,398,505 |
Total tax & extraordinary income/cost | -425,822 | -3,681,254 | -6,071,878 | -1,882,537 |
Annual Total Result | -1,455,022 | -9,533,948 | -17,150,598 | -3,515,968 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 34,962,927 | 11,635,669 | 8,029,415 | 1,882,537 |
Total current assets | 8,455,474 | 6,455,693 | 25,962,902 | 31,104,330 |
Total assets | 43,418,401 | 18,091,362 | 33,992,317 | 32,986,867 |
Short term debt | -966,408 | 23,877 | 6,390,884 | 226,916 |
Long term debt | 11,040,294 | 0 | 0 | 0 |
Total liabilities | 10,073,886 | 23,877 | 6,390,884 | 226,916 |
Contributed capital | 65,747,313 | 49,015,260 | 49,015,260 | 37,023,180 |
Retained earnings | -32,402,798 | -30,947,775 | -21,413,827 | -4,263,229 |
Total equity | 33,344,515 | 18,067,485 | 27,601,433 | 32,759,951 |
Total equity and liabilities | 43,418,401 | 18,091,362 | 33,992,317 | 32,986,867 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises